| Date | Sponsor | Speaker | Topic |
2009 |
|---|
| Nov | New Objective | Jarrod Marto | Multidimensional Fractionation Strategies
for Quantitative Proteomics |
| Oct | Corporate Night | Joshua J. Coon | How hybrid mass spectrometers with
multiple analyzers and dissociation methods will transform protein sequence analysis |
| Sep | Bruker Daltonics | Jonathan Sweedler | Using Mass Spectrometry
to Measure the Chemistry of the Brain |
| Jun | GBMSDG | Sabine Becker | Bio-Imaging of Metals
in Thin Tissue Sections of Brain by Laser Ablation Inductively Coupled Plasma Mass Spectrometry (LA-ICP-MS)
Combined to Metallomics The New Challenge for Neuroscience |
| Apr | Agilent | Paul R. West | Predicting Human
Developmental Toxicity Using Human Embryonic Stem Cells and Metabolomics |
| Mar | Wyeth | Alan G. Marshall | Reading Chemical
"Fine Print": The Key to Exploiting Nature's Isotopic Complexity |
| Feb | GBMSDG | Richard W. Vachet | Insight into β-2-Microglobulin Amyloid
Fibril Formation using Mass Spectrometry |
| Jan | GBMSDG | Catherine Costello | Revolutions in Mass Spectrometry-Based
Glycoprotein Analysis |
2008 |
|---|
| Nov | New Objective | Michael MacCoss | Targeted and
Discovery Based Proteomics: Complementary Approaches to Differential Proteomics |
| Oct | Corporate Night | Alfred Yergey | Spectral
Variability - Why We Don't Get Better Answers |
| Sep | Waters | David Clemmer | Using structural transitions to separate proteins in the gas
phase: Developing IMS-IMS-MS |
| May | Tenth Annual Symposium with MASSEP |
Milton Lee | Analytical Gradient Separation Methods |
| Ronald Orlando | Feeding the World to Curing Cancer: the Ever Expanding Role of Glycoproteomics |
| Mar | ThermoFisher and Genzyme | Daniel Magiera | Approaches to Bioanalysis:
Parallel Separations and On-line Sample Cleanup |
| Feb | GBMSDG | Jerrod Marto | Quantitative Analysis of Protein Complexes and Signaling Cascades:
Model Systems to Stem Cells |
2007 |
|---|
Dec | Brandeis University | Jeff Agar | Top-down for the masses: protein identification across
MS platforms |
| Oct | Corporate Night | Gary Siuzdak | Novel Approaches to Global Metabolomics |
| Sep | Bruker Daltonics | Peter O'Connor | Cryogenic FTICRMS |
| May | Ninth Annual Symposium with MASSEP |
Robert Kennedy | High-Throughput Separations |
| Julie Leary | Advancing the Frontiers of Structural Biology; Mass Spectrometry of Biological Binding Partners |
| Apr | AstraZeneca | Jack Henion | Chip-Based Nano Electrospray Mass Spectrometry: Background
and Applications for Studies in the Life Sciences |
| Apr | New Objective | Jim Stevenson | The Role of Peptide Isoelectric Point in Proteomics: from
pI Prediction to Gene Finding and Analysis of Single Nucleotide Polymorphisms |
| Mar | Thermo Fisher Scientific | Shalender Bhasin | Current Hurdles and Opportunities in the Widespread Application
of LC-MS/MS-based Hormone Assays in Clinical Practice |
| Feb | McKinley Scientific | Mike Lee | Future Directions in Quantitative Mass Spectrometry |
| Jan | Waters | John Engen | Protein Confirmation and Dynamics by Mass Spectrometry" |
2006 |
|---|
| Dec | Applied Biosystems | Martin Latterich | Comparative quantitation of biomarkers using MRM
approaches |
| Nov | Bruker Daltonics | Igor Kaltashov | When the Mass Does Not Matter: Characterization of
Protein Higher Order Structure by Mass Spectrometry |
| Oct | Shire HGT | Richard Caprioli | Imaging Mass Spectrometry |
| Sep | Agilent | Pierre Thibault | Microfluidics Devices with Integrated Separation Modules;
Expression Profiling Approaches for Bottom-Up and Top-down Proteomics Analyses |
| Aug | Beyond Genomics Medicine | Michael Grayson | History of Mass Spectrometry
|
| May | Eigth Annual Symposium with MASSEP |
Joseph Loo | Mass Spectrometry and Droplets: Elucidation of Protein Sequence and Complexes |
| Milos Novotny | Combining the Strengths of Separation Science and Mass Spectrometry in Solving Structural
Problems in Glycobiology |
| Apr | Wyeth Biopharmaceuticals | Scott Mcluckey | Gas-Phase Ion/Ion Reactions: Novel Chemistries
For Bio-Analysis Using Mass Spectrometry |
| Mar | AstraZeneca | Gary Van Berkel | Desorption Electrospray and Surface Sampling Probe
Approaches to Mass Spectrometric Sampling and Imaging of Surfaces |
| Feb | Immunogen | David Lubman | Searching for Markers of Cancer Using a 2-D Liquid Mapping
Technique and Mass Spectrometry |
2005 |
|---|
| Sep | McKinley Scientific | Joe Zaia | Principles and Practice of Mass Spectrometry for Glycomics |
| May | Seventh Annual Symposium with MASSEP | Jonathan Sweedler | Understanding
neurochemistry neuron by neuron:mass spectrometry and separations for neuroscience research |
| Fred McLafferty | Mass Spectrometry of Biomolecules |
2004 |
|---|
| Dec | University of New Hampshire | Donald F. Hunt | Comparative analysis of
phosphoproteins, the histone code and an approach towards a vaccine against cancer |
| Nov | Thermo Finnigan | Matthias Mann | Organellar and Signalling Proteomics with a
linear ion trap Fourier Transform mass spectrometer (LTQ-FT) |
| May | Sixth Annual Symposium with MASSEP | Norm Dovichi | Two-dimensional
Capillary Electrophoresis Separation of Complex Protein Samples |
| Catherine Costello | Mass Spectrometry Research in the Medical Arena: Refining Our
Tools and Seeking the Secrets of Nature |
| Apr | Bruker Daltonics | Paul Tempst | |
| Mar | Corporate Night |
| Feb | Bruker Daltonics | Karl Clauser | The role of
phosphoproteomics in advancing kinase targets through drug development |
2003 |
|---|
| Dec | Praecis Pharmaceuticals | Forest White | Phosphoproteome
Analysis by Mass Spectrometry |
| Nov | Waters | Jeremy Nicholson | Understanding global systems
biology via metabonomic analysis |
| Oct | Applied Biosystems | Edward Takach | Using MALDI TOF/TOF
MS/MS to Provide Simultaneous Drug/Metabolite Quantification and identification |
| Jul | Bruker Daltonics | John B. Fenn | |
| May | Fifth Annual Symposium with MASSEP | Ed Yeung | High Throughput Screening
Based on Multiplexed CE and Absorption Detection |
| Stephen Naylor | The Role of Mass Spectrometry in Systems Biology |
| Apr | Biogen | Dr. Pete Wishnok | Protein and DNA interactions
with genotoxins. Analysis by traditional and not-so-traditional mass spectrometry |
| Apr | Corporate Night |
| Feb | Thermo Finnigan | Paul Vouros | Trace analysis of biopharmaceutical
compounds using micro LC-MS techniques |
2002 |
|---|
| Oct | Applied Biosystems | Darryl Pappin | Derivatization
of peptides to facilitate de novo sequencing |
| Sep | Boston University School of Medicine | Peter O'Connor |
Advantages, challenges, and solutions in the design of cryogenic FTMS |
| May | Fourth Annual Symposium with MASSEP | David Hage |
Rapid affinity analyis in the millisecond-to-second time domain |
| Steve Carr | Functional proteomics in drug discovery |
| Mar | Corporate Night |
| Feb | Genzyme | Steven Gygi | Brand New Approaches to Protein
Quantification and Characterization |
2001 |
|---|
| Dec | Applied Biosystems | Jennifer Campbell | Automated
MALDI-TOF-TOF for High-Throughput Protein Identification and Characterization |
| Sep | Millipore | Malcolm Pluskal |
Development of a multiwell in-gel digest kit and microscale sample preparation
for protein characterization by MS |
| Mike Colman | High-throughput sample preparation for SNP genotyping
analysis by MALDI-TOF mass spectrometry |
| Jul | Bruker Daltonics | Tom Brenna | High precision isotope
ratio mass spectrometry for high sensitivity tracer studies of polyunsaturated fatty
acid metabolism in perinatal primates (including humans) |
| May | Third Annual Symposium with MASSEP | Roland Annan |
The Prospects and Challenges of Proteomics |
| William Hancock | Proteomics: A New Challenge for Separation Science |
| Mar | Corporate Night |
2000 |
|---|
Dec | Micromass | Allen Annis | An Affinity Selection - Mass Spectral Method
for the Identification of Small Molecule Ligands from Self-Encoded Combinatorial Libraries |
| Nov | Applied Biosystems | Peter Roepstorf |
Proteomics: Where are we and where do we go? |
| Ole Norregaard Jensen | New approaches to phosphopeptide and phosphoprotein
analysis by MS and MS/MS |
| Finn Kirpekar | RNA analysis by MALDI-MS and MALDI-MS/MS |
| Oct | Millennium Pharmaceuticals | Joe Zaia | Identification
of functionally relevant glycosaminoglycan sub-structures using mass spectrometry |
